Decker Retirement Planning’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75K Sell
30
-370
-93% -$48.8K ﹤0.01% 299
2026
Q1
$55.7K Buy
400
+388
+3,233% +$54.3K 0.03% 89
2025
Q4
$1.47K Hold
12
﹤0.01% 206
2025
Q3
$1.33K Sell
12
-67
-85% -$7.62K ﹤0.01% 202
2025
Q2
$8.76K Sell
79
-43,079
-100% -$4.58M 0.01% 176
2025
Q1
$4.84M Buy
43,158
+42,840
+13,472% +$4.42M 3.01% 5
2024
Q4
$29.4K Buy
+318
New +$28.6K 0.02% 159

Other funds holding GILD

Decker Retirement Planning's GILD Position: Q2 2026 in Review

Decker Retirement Planning reduced its Gilead Sciences (GILD) stake by 93% in Q2 2026, selling an estimated $48.8K and leaving 30 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #299.

Decker Retirement Planning first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.84M in Q1 2025. 907 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Decker Retirement Planning held 30 shares of Gilead Sciences worth $3.75K as of Q2 2026.
  • Decker Retirement Planning sold 370 Gilead Sciences shares in Q2 2026, an estimated $48.8K.
  • Gilead Sciences made up ﹤0.01% of Decker Retirement Planning's portfolio in Q2 2026, its #299 holding.
  • Decker Retirement Planning first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Decker Retirement Planning's Gilead Sciences position peaked at $4.84M in Q1 2025.
  • 907 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Decker Retirement Planning's 13F filing for Q2 2026, filed 16 Jul 2026.